Results 141 to 150 of about 44,151 (306)
International Journal of Nanomedicine, 2015 Dandan Liu,1 Hao Pan,2 Fengwei He,1 Xiaoyu Wang,3 Jinyu Li,3 Xinggang Yang,3 Weisan Pan31Department of Pharmaceutical Engineering, School of Biomedical and Chemical Engineering, Liaoning Institute of Science and Technology, Benxi, People’s Republic
Liu DD +6 more
doaj
Carvedilol-Afforded Protection against Daunorubicin-Induced Cardiomyopathic Rats In Vivo: Effects on Cardiac Fibrosis and Hypertrophy [PDF]
, 2011 Anthracyclines, most powerful anticancer agents, suffer from their cardiotoxic effects, which may be due to the induction of oxidative stress. Carvedilol, a third-generation, nonselective β-adrenoreceptor antagonist, possesses both reactive oxygen ...
Arozal, Wawaimuli +12 more
core +3 more sources
Clinical and Translational Science, Volume 18, Issue 5, May 2025.ABSTRACT Previous pharmacogenetic findings for beta‐blocker pharmacodynamic candidate genes (ADRB1, ADRB2, ADRA2C, GRK4, and GRK5) have been inconsistent. Therefore, the purpose of this study was to determine whether interactions of pharmacodynamic variants with beta‐blocker exposure significantly associated with survival in patients with heart failure
Jasmine A. Luzum +5 more
wiley +1 more source
Dilated cardiomyopathy in childhood [PDF]
, 2000 Dilated Cardiomyopathy is an uncommon disease in children but morbidity and mortality in affected patients are high. This review discuses clinical presentation, diagnosis, medical management and prognosis of the condition, with an emphasis on recent ...
Franklin, O.M.
core
Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure [PDF]
, 2004 ObjectivesThe purpose of this research was to evaluate the therapeutic value of initiating a beta-blocker before an angiotensin-converting enzyme inhibitor (ACEI) in the treatment of heart failure.BackgroundAlthough ACEI and carvedilol produce benefits ...
Candy, Geoffrey +8 more
core +1 more source
Impact of Variability in Blood Pressure and Heart Rate on Beta‐Blocker Adherence
The Journal of Clinical Hypertension, Volume 27, Issue 5, May 2025.ABSTRACT Adherence to antihypertensive medications is essential for blood pressure (BP) control, influencing long‐term outcomes in hypertensive patients. This study examines the association between visit‐to‐visit variability in BP and heart rate (HR) and its effect on adherence to beta‐blocker therapy among outpatients.
Yan Li +9 more
wiley +1 more source
International Journal of Molecular Sciences, 2019 The effects of remote ischemic preconditioning (RIPC) in cardiac surgery have been inconsistent. We investigated whether anesthesia or beta-blockers interfere with RIPC cardioprotection.
Y. Cho +6 more
semanticscholar +1 more source
Nano and Microparticulate Chitosan Based System for Formulation of Carvedilol Rapid Melt Tablet
Advanced Pharmaceutical Bulletin, 2015 Purpose: In the present study rapid melt tablets (RMT’s) of carvedilol were prepared by using ionotropic-gelated chitosan nanoparticles using a spray-drying method.
Ravindra Patil +2 more
doaj +1 more source
Pepducins as a potential treatment strategy for asthma and COPD. [PDF]
, 2018 Current therapies to treat asthma and other airway diseases primarily include anti-inflammatory agents and bronchodilators. Anti-inflammatory agents target trafficking and resident immunocytes and structural cells, while bronchodilators act to prevent or
Benovic, Jeffrey L. +4 more
core +2 more sources
Liver International, Volume 45, Issue 5, May 2025.ABSTRACT Background & Aims HVPG is the gold standard for the diagnosis of clinically significant portal hypertension (CSPH), a condition associated with the risk of developing hepatic decompensation events. However, HVPG is an indirect method to measure portal pressure, and its application in the pre‐sinusoidal form of portal hypertension (PH), as in ...
Francesco Santopaolo +12 more
wiley +1 more source